This government services opportunity from FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI is open for bids until 23 November 2026. The estimated contract value ranges from EUR 2,024,000+. Sign up free to see your personalized fit score and generate an AI proposal.
Listed on AutoTender:
The full notice is free at the source (linked above). AutoTender reads it for you and adds:
Already have an account? Log in
This tender, "PROCEDURA APERTA PER L’AFFIDAMENTO AD UNA CONTRACT RESEARCH ORGANIZATION (CRO) DEI SERVIZI PER LA GESTIONE DELLO STUDIO CLINICO MULTICENTRICO RANDOMIZZATO: “COMBOSEQ - SEQUENCE STRATEGY OF IMMUNEONCOLOGY (IO-IO) VS IO-TYROSINE KINASE INHIBITORS (TKI) FOLLOWED BY TKI IN METASTATIC RENAL CELL CARCINOMA (MRCC): A RANDOMIZED PHASE 3 STUDY MEETURO AND FICOG TRIAL”, MEDIANTE PIATTAFORMA SINTEL", is a government services opportunity published by FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI. It is listed on AutoTender for businesses seeking government contract opportunities.
The submission deadline is 23 November 2026, which is 20 days from now. Early preparation is recommended as government tenders often require detailed documentation.
The estimated contract value ranges from EUR 2,024,000+. Final award values may vary depending on the scope of the successful bid.
This opportunity was originally published on TED (Tenders Electronic Daily). AutoTender aggregates opportunities from 64 government portals worldwide.
Sign up for a free AutoTender account to see the full tender requirements, get your personalized fit score, and generate an AI-powered proposal. The Scout plan is free and requires no credit card.
AutoTender tracks live government opportunities across 40 countries. See your TED fit score.
Browse more opportunities →We use essential cookies to run the site and, if you agree, analytics to see how it is used and fix errors. We never sell your data. Cookie Policy